Amylyx Pharmaceuticals, Inc. Common Stock

AMLXNASDAQ • USD
28.41 USD
↘ 1.88 (6.21%)🟢LIVE (AS OF 01:22 PM EST)
🟢Market: OPEN

Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) is currently trading at $28.41. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. AMLX is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$30.19
High?$31.48
Low?$28.27
Prev. Close?$30.29
Volume?652.2K
Avg. Volume?1.4M
VWAP?$29.45
Rel. Volume?0.46x
Bid / Ask
Bid?$28.44 × 100
Ask?$30.32 × 100
Spread?$1.88
Midpoint?$29.38
Valuation & Ratios
Market Cap?3.9B
Shares Out?128.6M
Float?96.4M
Float %?86.5%
P/E Ratio?N/A
P/B Ratio?5.17
EPS?-$1.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
Employees
136
Market Cap
3.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-01-07
Address
55 CAMBRIDGE PARKWAY
CAMBRIDGE, MA 02142
Phone: 617-682-0917
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?69.51Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.31%High
Short Interest?12.8M
Days to Cover?10.5
Free Float96.4M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?26.81Strong
Quick Ratio?26.81Strong
Cash Ratio?8.27Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
36
5.17FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-20.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-21.7%WEAK▾
ROA?
S&P
3
-20.7%WEAK▾
Cash Flow & Enterprise
FCF?$-130024000
Enterprise Value?$3.7B
Fundamentals ratios updated end of day